Monday, 28 February 2011 20:12

Quality assurance

Rate this item
(1 Vote)

Decisions affecting the health, well-being, and employability of individual workers or an employer’s approach to health and safety issues must be based on data of good quality. This is especially so in the case of biological monitoring data and it is therefore the responsibility of any laboratory undertaking analytical work on biological specimens from working populations to ensure the reliability, accuracy and precision of its results. This responsibility extends from providing suitable methods and guidance for specimen collection to ensuring that the results are returned to the health professional responsible for the care of the individual worker in a suitable form. All these activities are covered by the expression of quality assurance.
The central activity in a quality assurance programme is the control and maintenance of analytical accuracy and precision. Biological monitoring laboratories have often developed in a clinical environment and have taken quality assurance techniques and philosophies from the discipline of clinical chemistry. Indeed, measurements of toxic chemicals and biological effect indicators in blood and urine are essentially no different from those made in clinical chemistry and in clinical pharmacology service laboratories found in any major hospital.
A quality assurance programme for an individual analyst starts with the selection and establishment of a suitable method. The next stage is the development of an internal quality control procedure to maintain precision; the laboratory needs then to satisfy itself of the accuracy of the analysis, and this may well involve external quality assessment (see below). It is important to recognize however, that quality assurance includes more than these aspects of analytical quality control.

Method Selection
There are several texts presenting analytical methods in biological monitoring. Although these give useful guidance, much needs to be done by the individual analyst before data of suitable quality can be produced. Central to any quality assurance programme is the production of a laboratory protocol that must specify in detail those parts of the method which have the most bearing on its reliability, accuracy, and precision. Indeed, national accreditation of laboratories in clinical chemistry, toxicology, and forensic science is usually dependent on the quality of the laboratory’s protocols. Development of a suitable protocol is usually a time-consuming process. If a laboratory wishes to establish a new method, it is often most cost-effective to obtain from an existing laboratory a protocol that has proved its performance, for example, through validation in an established international quality assurance programme. Should the new laboratory be committed to a specific analytical technique, for example gas chromatography rather than high-performance liquid chromatography, it is often possible to identify a laboratory that has a good performance record and that uses the same analytical approach. Laboratories can often be identified through journal articles or through organizers of various national quality assessment schemes.

Internal Quality Control
The quality of analytical results depends on the precision of the method achieved in practice, and this in turn depends on close adherence to a defined protocol. Precision is best assessed by the inclusion of “quality control samples” at regular intervals during an analytical run. For example, for control of blood lead analyses, quality control samples are introduced into the run after every six or eight actual worker samples. More stable analytical methods can be monitored with fewer quality control samples per run. The quality control samples for blood lead analysis are prepared from 500 ml of blood (human or bovine) to which inorganic lead is added; individual aliquots are stored at low temperature (Bullock, Smith and Whitehead 1986). Before each new batch is put into use, 20 aliquots are analysed in separate runs on different occasions to establish the mean result for this batch of quality control samples, as well as its standard deviation (Whitehead 1977). These two figures are used to set up a Shewhart control chart (figure 27.2). The results from the analysis of the quality control samples included in subsequent runs are plotted on the chart. The analyst then uses rules for acceptance or rejection of an analytical run depending on whether the results of these samples fall within two or three standard deviations (SD) of the mean. A sequence of rules, validated by computer modelling, has been suggested by Westgard et al. (1981) for application to control samples. This approach to quality control is described in textbooks of clinical chemistry and a simple approach to the introduction of quality assurance is set forth in Whitehead (1977). It must be emphasized that these techniques of quality control depend on the preparation and analysis of quality control samples separately from the calibration samples that are used on each analytical occasion.

Figure 27.2 Shewhart control chart for quality control samples


This approach can be adapted to a range of biological monitoring or biological effect monitoring assays. Batches of blood or urine samples can be prepared by addition of either the toxic material or the metabolite that is to be measured. Similarly, blood, serum, plasma, or urine can be aliquotted and stored deep-frozen or freeze-dried for measurement of enzymes or proteins. However, care has to be taken to avoid infective risk to the analyst from samples based on human blood.
Careful adherence to a well-defined protocol and to rules for acceptability is an essential first stage in a quality assurance programme. Any laboratory must be prepared to discuss its quality control and quality assessment performance with the health professionals using it and to investigate surprising or unusual findings.

External Quality Assessment
Once a laboratory has established that it can produce results with adequate precision, the next stage is to confirm the accuracy (“trueness”) of the measured values, that is, the relationship of the measurements made to the actual amount present. This is a difficult exercise for a laboratory to do on its own but can be achieved by taking part in a regular external quality assessment scheme. These have been an essential part of clinical chemistry practice for some time but have not been widely available for biological monitoring. The exception is blood lead analysis, where schemes have been available since the 1970s (e.g., Bullock, Smith and Whitehead 1986). Comparison of analytical results with those reported from other laboratories analysing samples from the same batch allows assessment of a laboratory’s performance compared with others, as well as a measure of its accuracy. Several national and international quality assessment schemes are available. Many of these schemes welcome new laboratories, as the validity of the mean of the results of an analyte from all the participating laboratories (taken as a measure of the actual concentration) increases with the number of participants. Schemes with many participants are also more able to analyse laboratory performance according to analytical method and thus advise on alternatives to methods with poor performance characteristics. In some countries, participation in such a scheme is an essential part of laboratory accreditation. Guidelines for external quality assessment scheme design and operation have been published by the WHO (1981).
In the absence of established external quality assessment schemes, accuracy may be checked using certified reference materials which are available on a commercial basis for a limited range of analytes. The advantages of samples circulated by external quality assessment schemes are that (1) the analyst does not have fore-knowledge of the result, (2) a range of concentrations is presented, and (3) as definitive analytical methods do not have to be employed, the materials involved are cheaper.

Pre-analytical Quality Control
Effort spent in attaining good laboratory accuracy and precision is wasted if the samples presented to the laboratory have not been taken at the correct time, if they have suffered contamination, have deteriorated during transport, or have been inadequately or incorrectly labelled. It is also bad professional practice to submit individuals to invasive sampling without taking adequate care of the sampled materials. Although sampling is often not under the direct control of the laboratory analyst, a full quality programme of biological monitoring must take these factors into account and the laboratory should ensure that syringes and sample containers provided are free from contamination, with clear instructions about sampling technique and sample storage and transport. The importance of the correct sampling time within the shift or working week and its dependence on the toxicokinetics of the sampled material are now recognized (ACGIH 1993; HSE 1992), and this information should be made available to the health professionals responsible for collecting the samples.

Post-analytical Quality Control
High-quality analytical results may be of little use to the individual or health professional if they are not communicated to the professional in an interpretable form and at the right time. Each biological monitoring laboratory should develop reporting procedures for alerting the health care professional submitting the samples to abnormal, unexpected, or puzzling results in time to allow appropriate action to be taken. Interpretation of laboratory results, especially changes in concentration between successive samples, often depends on knowledge of the precision of the assay. As part of total quality management from sample collection to return of results, health professionals should be given information concerning the biological monitoring laboratory’s precision and accuracy, as well as reference ranges and advisory and statutory limits, in order to help them in interpreting the results. 


Click to return to top of page

Read 6353 times Last modified on Thursday, 11 August 2022 15:26

" DISCLAIMER: The ILO does not take responsibility for content presented on this web portal that is presented in any language other than English, which is the language used for the initial production and peer-review of original content. Certain statistics have not been updated since the production of the 4th edition of the Encyclopaedia (1998)."


Biological Monitoring References

Alcini, D, M Maroni, A Colombi, D Xaiz, and V Foà. 1988. Evaluation of a standardised European method for the determination of cholinesterase activity in plasma and erythrocytes. Med Lavoro 79(1):42-53.

Alessio, L, A Berlin, and V Foà. 1987. Influence factors other than exposure on the levels of biological indicators. In Occupational and Environmental Chemical Hazards, edited by V Foà, FA Emmett, M Maroni, and A Colombi. Chichester: Wiley.

Alessio, L, L Apostoli, L Minoia, and E Sabbioni. 1992. From macro- to micro-doses: Reference values for toxic metals. In Science of the Total Environment, edited by L Alessio, L Apostoli, L Minoia, and E Sabbioni. New York: Elsevier Science.

American Conference of Governmental Industrial Hygienists (ACGIH). 1997. 1996-1997 Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. Cincinnati, Ohio: ACGIH.

—. 1995. 1995-1996 Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. Cincinnati, Ohio: ACGIH.

Augustinsson, KB. 1955. The normal variation of human blood cholinesterase activity. Acta Physiol Scand 35:40-52.

Barquet, A, C Morgade, and CD Pfaffenberger. 1981. Determination of organochlorine pesticides and metabolites in drinking water, human blood, serum and adipose tissue. J Toxicol Environ Health 7:469-479.

Berlin, A, RE Yodaiken, and BA Henman. 1984. Assessment of Toxic Agents at the Workplace. Roles of Ambient and Biological Monitoring. Proceedings of the International Seminar held in Luxembourg, December 8-12. 1980. Lancaster, UK: Martinus Nijhoff.

Bernard, A and R Lauwerys. 1987. General principles for biological monitoring of exposure to chemicals. In Biological Monitoring of Exposure to Chemicals: Organic Compounds, edited by MH Ho and KH Dillon. New York: Wiley.

Brugnone, F, L Perbellini, E Gaffuri, and P Apostoli. 1980. Biomonitoring of industrial solvent exposure of workers’ alveolar air. Int Arch Occup Environ Health 47:245-261.

Bullock, DG, NJ Smith, and TP Whitehead. 1986. External quality assessment of assays of lead in blood. Clin Chem 32:1884-1889.

Canossa, E, G Angiuli, G Garasto, A Buzzoni, and E De Rosa. 1993. Dose indicators in farm workers exposed to mancozeb. Med Lavoro 84(1):42-50.

Catenacci, G, F Barbieri, M Bersani, A Ferioli, D Cottica, and M Maroni. 1993. Biological monitoring of human exposure to atrazine. Toxicol Letters 69:217-222.

Chalermchaikit, T, LJ Felice, and MJ Murphy. 1993. Simultaneous determination of eight anticoagulant rodenticides in blood serum and liver. J Anal Toxicol 17:56-61.

Colosio, C, F Barbieri, M Bersani, H Schlitt, and M Maroni. 1993. Markers of occupational exposure to pentachlorophenol. B Environ Contam Tox 51:820-826.

Commission of the European Communities (CEC). 1983. Biological indicators for the assessment of human exposure to industrial chemicals. In EUR 8676 EN, edited by L Alessio, A Berlin, R Roi, and M Boni. Luxembourg: CEC.

—. 1984. Biological indicators for the assessment of human exposure to industrial chemicals. In EUR 8903 EN, edited by L Alessio, A Berlin, R Roi, and M Boni. Luxembourg: CEC.

—. 1986. Biological indicators for the assessment of human exposure to industrial chemicals. In EUR 10704 EN, edited by L Alessio, A Berlin, R Roi, and M Boni. Luxembourg: CEC.

—. 1987. Biological indicators for the assessment of human exposure to industrial chemicals. In EUR 11135 EN, edited by L Alessio, A Berlin, R Roi, and M Boni. Luxembourg: CEC.

—. 1988a. Biological indicators for the assessment of human exposure to industrial chemicals. In EUR 11478 EN, edited by L Alessio, A Berlin, R Roi, and M Boni. Luxembourg: CEC.

—. 1988b. Indicators for Assessing Exposure and Biological Effects of Genotoxic Chemicals. EUR 11642 Luxembourg: CEC.

—. 1989. Biological indicators for the assessment of human exposure to industrial chemicals. In EUR 12174 EN, edited by L Alessio, A Berlin, R Roi, and M Boni. Luxembourg: CEC.

Cranmer, M. 1970. Determination of p-nitrophenol in human urine. B Environ Contam Tox 5:329-332.

Dale, WE, A Curley, and C Cueto. 1966. Hexane extractable chlorinated insecticides in human blood. Life Sci 5:47-54.

Dawson, JA, DF Heath, JA Rose, EM Thain, and JB Ward. 1964. The excretion by humans of the phenol derived in vivo from 2-isopropoxyphenyl-N-methylcarbamate. Bull WHO 30:127-134.

DeBernardis, MJ and WA Wargin. 1982. High performance liquid chromatographic determination of carbaryl and 1 naphtol in biological fluids. J Chromatogr 246:89-94.

Deutsche Forschungsgemeinschaft (DFG). 1996. Maximum Concentrations At the Workplace (MAK) and Biological Tolerance Values (CBAT) for Working Materials. Report No.28.VCH. Weinheim, Germany: Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area.

—. 1994. List of MAK and BAT Values 1994. Weinheim, Germany: VCH.

Dillon, HK and MH Ho. 1987. Biological monitoring of exposure to organophosphorus pesticides. In Biological Monitoring of Exposure to Chemicals: Organic Compounds, edited by HK Dillon and MH Ho. New York: Wiley.

Draper, WM. 1982. A multiresidue procedure for the determination and confirmation of acidic herbicide residues in human urine. J Agricul Food Chem 30:227-231.

Eadsforth, CV, PC Bragt, and NJ van Sittert. 1988. Human dose-excretion studies with pyrethroid insecticides cypermethrin and alphacypermethrin: Relevance for biological monitoring. Xenobiotica 18:603-614.

Ellman, GL, KD Courtney, V Andres, and RM Featherstone. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95.

Gage, JC. 1967. The significance of blood cholinesterase activity measurements. Residue Rev 18:159-167.

Health and Safety Executive (HSE). 1992. Biological Monitoring for Chemical Exposures in the Workplace. Guidance Note EH 56. London: HMSO.

International Agency for Research on Cancer (IARC). 1986. IARC Monographs On the Evaluation of Carcinogenic Risks to Humans - An Updating of (Selected) IARC Monographs from Volumes 1 to 42. Supplement 6: Genetic and related effects; Supplement 7: Overall evaluation of carcinogenicity. Lyon: IARC.

—. 1987. Method for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention. IARC Scientific Publications, No.89, edited by H Bartsch, K Hemminki, and IK O’Neill. Lyon: IARC.

—. 1992. Mechanisms of Carcinogenesis in Risk Identification. IARC Scientific Publications, No.116, edited by H Vainio. Lyon: IARC.

—. 1993. DNA Adducts: Identification and Biological Significance. IARC Scientific Publications, No.125, edited by K Hemminki. Lyon: IARC.

Kolmodin-Hedman, B, A Swensson, and M Akerblom. 1982. Occupational exposure to some synthetic pyrethroids (permethrin and fenvalerate). Arch Toxicol 50:27-33.

Kurttio, P, T Vartiainen, and K Savolainen. 1990. Environmental and biological monitoring of exposure to ethylenebisdithiocarbamate fungicides and ethylenethiourea. Br J Ind Med 47:203-206.

Lauwerys, R and P Hoet. 1993. Industrial Chemical Exposure: Guidelines for Biological Monitoring. Boca Raton: Lewis.

Laws, ERJ. 1991. Diagnosis and treatment of poisoning. In Handbook of Pesticide Toxicology, edited by WJJ Hayes and ERJ Laws. New York: Academic Press.

Lucas, AD, AD Jones, MH Goodrow, and SG Saiz. 1993. Determination of atrazine metabolites in human urine: Development of a biomarker of exposure. Chem Res Toxicol 6:107-116.

Maroni, M, A Ferioli, A Fait, and F Barbieri. 1992. Messa a punto del rischio tossicologico per l’uomo connesso alla produzione ed uso di antiparassitari. Prev Oggi 4:72-133.

Reid, SJ and RR Watts. 1981. A method for the determination of diaklyl phosphate residues in urine. J Anal Toxicol 5.

Richter, E. 1993. Organophosphorus Pesticides: A Multinational Epidemiologic Study. Copenhagen: Occupational Health Programme and WHO Regional Office for Europe.

Shafik, MT, DE Bradway, HR Enos, and AR Yobs. 1973a. Human exposure to organophosphorous pesticides: A modified procedure for the gas-liquid chromatographic analysis of the alkyl phosphate metabolites in urine. J Agricul Food Chem 21:625-629.

Shafik, MT, HC Sullivan, and HR Enos. 1973b. Multiresidue procedure for halo- and nitrophenols: Measurements of exposure to biodegradable pesticides yielding these compounds as metabolites. J Agricul Food Chem 21:295-298.

Summers, LA. 1980. The Bipyridylium Herbicides. London: Academic Press.

Tordoir, WF, M Maroni, and F He. 1994. Health surveillance of pesticide workers: A manual for occupational health professionals. Toxicology 91.

US Office of Technology Assessment. 1990. Genetic Monitoring and Screening in the Workplace. OTA-BA-455. Washington, DC: US Government Printing Office.

van Sittert, NJ and EP Dumas. 1990. Field study on exposure and health effects of an organophosphate pesticide for maintaining registration in the Philippines. Med Lavoro 81:463-473.

van Sittert, NJ and WF Tordoir. 1987. Aldrin and dieldrin. In Biological Indicators for the Assessment of Human Exposure to Industrial Chemicals, edited by L Alessio, A Berlin, M Boni, and R Roi. Luxembourg: CEC.

Verberk, MM, DH Brouwer, EJ Brouer, and DP Bruyzeel. 1990. Health effects of pesticides in the flower-bulb culture in Holland. Med Lavoro 81(6):530-541.

Westgard, JO, PL Barry, MR Hunt, and T Groth. 1981. A multirule Shewhart chart for quality control in clinical chemistry. Clin Chem 27:493-501.

Whitehead, TP. 1977. Quality Control in Clinical Chemistry. New York: Wiley.

World Health Organization (WHO). 1981. External Quality Assessment of Health Laboratories. EURO Reports and Studies 36. Copenhagen: WHO Regional Office for Europe.

—. 1982a. Field Survey of Exposure to Pesticides, Standard Protocol. Document. No. VBC/82.1 Geneva: WHO.

—. 1982b. Recommended Health-Based Limits in Occupational Exposure to Pesticides. Technical Report Series, No.677. Geneva: WHO.

—. 1994. Guidelines in Biological Monitoring of Chemical Exposure at the Workplace. Vol. 1. Geneva: WHO.